Stocks

The table gives an overview of all stocks, alphabetically sorted.
 Kadant, Inc. KAI Mar 5, 2021 175.48 +2.89   
 Kadmon Holdings, Inc. KDMN Mar 5, 2021 4.61 -0.86   
 Kairos Acquisition Corp. - Unit KAIRU Mar 5, 2021 10.29 0.00   
 Kaiser Aluminum Corporation KALU Mar 5, 2021 114.61 +2.84   
 Kaixin Auto Holdings - Ordinary Share KXIN Mar 5, 2021 2.99 +7.55   
 Kala Pharmaceuticals, Inc. KALA Mar 5, 2021 7.12 +0.42   
 Kaleido Biosciences, Inc. KLDO Mar 5, 2021 8.81 -3.93   
 Kaleyra, Inc. KLR Mar 5, 2021 16.92 -0.99   
 KalVista Pharmaceuticals, Inc. KALV Mar 5, 2021 30.88 -2.15   
 Kamada Ltd. - Ordinary Shares KMDA Mar 5, 2021 6.10 +1.33   
 Kaman Corporation KAMN Mar 5, 2021 53.06 +5.19   
 Kandi Technologies Group, Inc. KNDI Mar 5, 2021 6.10 -2.09   
 Kansas City Southern KSU Mar 5, 2021 211.69 +5.16   
 Kansas City Southern 4% PRF PERPETUAL USD 25 KSU- Mar 5, 2021 38.85 +1.68   
 KAR Auction Services, Inc KAR Mar 5, 2021 14.25 +3.19   
 Karuna Therapeutics, Inc. KRTX Mar 5, 2021 120.75 +2.54   
 Karyopharm Therapeutics Inc. KPTI Mar 5, 2021 11.63 +0.35   
 Kaspien Holdings Inc. KSPN Mar 5, 2021 30.49 +5.90   
 Kayne Anderson Energy Infrastructure Fund, Inc. KYN Mar 5, 2021 7.13 +0.28   
 Kayne Anderson NextGen Energy & Infrastructure, Inc. KMF Mar 5, 2021 6.29 +0.16   
 Kazia Therapeutics Limited - American Depositary Shares KZIA Mar 5, 2021 9.48 +1.28   
 KB Financial Group Inc KB Mar 5, 2021 41.63 +4.28   
 KB Home KBH Mar 5, 2021 42.63 +7.84   
 KBR, Inc. KBR Mar 5, 2021 31.02 +1.24   
 KBS Fashion Group Limited KBSF Mar 5, 2021 3.09 -6.65   
 KBW Bank Powershares KBWB Mar 5, 2021 61.09 +1.73   
 KBW High Div Yield Financial Powershares KBWD Mar 5, 2021 18.81 +0.86   
 KBW Prem Yield Equity REIT Powershares KBWY Mar 5, 2021 22.13 +1.00   
 KBW Prop & Casuality Insur Powershares KBWP Mar 5, 2021 73.40 +2.90   
 KBW Regional Banking Powershares KBWR Mar 5, 2021 61.97 +3.55   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK